The Clinical Core (CC) will provide a structure for recruitment, characterization and enrollment of patients involved in the CCNMD proposed research protocols, in particular projects by Abi-Dargham and Laruelle, while maintaining the highest standards of safety and ethics. Missions of the core will include: 1) Recruitment. Recruitment will be centralized and will target a broad range of patients with schizophrenia including first episode patients; chronic patients in acute exacerbation; stable outpatients; chronic inpatient s in state facilities. Controls wilt be recruited from the Normal Controls Unit at the New York State Psychiatric Institute (NYSPI). 2) Diagnosis / Assessment. We will rigorously diagnose patients participating in the CCNMD' s research protocols and characterize their conditions across multiple domains of psychopathology (e.g. trait-related symptom, course of illness, and neurocognitive variables). We will ensure uniformity of assessmenfs and measures over timei by centralizing the training of raters to achieve and maintain interrater reiiability. 3) We will oversee the flow of patients between the dlfferent protocols while oni the Schizophrenia Research Unit at NYSPt (SRU), and their treatment and follow up in the Schizophrenia Research Clinic (SRC). We will also colllect blood samples for genetic studies which will be centralized in Conrad Giiiiam's Genome Center. 4) Committee for Eillics and Safety: This committee will review the ethical aspects of all studies. In particular, issues relating to medication washouts and capacity evaluations in vulnerable populations will be at the center of this committee's concerns, to ensure protection and safety of research subjects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH066171-03
Application #
7248772
Study Section
Special Emphasis Panel (ZMH1)
Project Start
Project End
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
3
Fiscal Year
2006
Total Cost
$87,730
Indirect Cost
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Slifstein, Mark; van de Giessen, Elsmarieke; Van Snellenberg, Jared et al. (2015) Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry 72:316-24
Chuhma, Nao; Mingote, Susana; Moore, Holly et al. (2014) Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling. Neuron 81:901-12
Poels, E M P; Kegeles, L S; Kantrowitz, J T et al. (2014) Imaging glutamate in schizophrenia: review of findings and implications for drug discovery. Mol Psychiatry 19:20-9
Poels, Eline M P; Kegeles, Lawrence S; Kantrowitz, Joshua T et al. (2014) Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings. Schizophr Res 152:325-32
Poels, Eline M P; Girgis, Ragy R; Thompson, Judy L et al. (2013) In vivo binding of the dopamine-1 receptor PET tracers [¹¹C]NNC112 and [¹¹C]SCH23390: a comparison study in individuals with schizophrenia. Psychopharmacology (Berl) 228:167-74
Kisby, Glen E; Moore, Holly; Spencer, Peter S (2013) Animal models of brain maldevelopment induced by cycad plant genotoxins. Birth Defects Res C Embryo Today 99:247-55
Mihali, Andra; Subramani, Shreya; Kaunitz, Genevieve et al. (2012) Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery. Expert Rev Neurother 12:785-99
Ward, Ryan D; Simpson, Eleanor H; Richards, Vanessa L et al. (2012) Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia. Neuropsychopharmacology 37:1699-707
Abi-Dargham, Anissa; Xu, Xiaoyan; Thompson, Judy L et al. (2012) Increased prefrontal cortical D? receptors in drug naive patients with schizophrenia: a PET study with [¹¹C]NNC112. J Psychopharmacol 26:794-805
Li, Yan-Chun; Kellendonk, Christoph; Simpson, Eleanor H et al. (2011) D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex. Proc Natl Acad Sci U S A 108:12107-12

Showing the most recent 10 out of 31 publications